Mycobacterium chimaera is a species of non-tuberculous mycobacteria (NTM) that can cause infections, particularly in individuals with weakened immune systems or those who have undergone cardiac surgery. M. chimaera infections have gained attention due to outbreaks linked to contaminated heater-cooler units used during open-heart surgeries.
Key Features
-
Source of Infection: M. chimaera has been found in the water tanks of heater-cooler units used during cardiopulmonary bypass surgeries. These devices are essential for controlling the temperature of the patient’s blood and organs during surgery. Contaminated water can aerosolize the bacteria, which can then enter the surgical field and potentially infect patients.
-
Infection Risk: Individuals most at risk for M. chimaera infection include those who have undergone open-heart surgery, particularly involving prosthetic material like heart valves. The infection can occur months to years after the surgical procedure, making diagnosis challenging.
Symptoms
M. chimaera infection can present with non-specific and systemic symptoms, which may include:
- Persistent fever
- Night sweats
- Weight loss
- Fatigue
- Muscle and joint pain
- Respiratory symptoms (e.g., cough, shortness of breath)
- Signs of prosthetic valve endocarditis or infection at the surgical site
- Symptoms related to disseminated infection, particularly in immunocompromised individuals
Diagnosis
Diagnosing M. chimaera infection requires a high index of suspicion, especially in patients with a history of cardiac surgery. Diagnostic steps include:
- Clinical Evaluation: Detailed medical history and physical examination, focusing on symptoms and history of cardiac surgery.
- Microbiological Tests: Blood cultures, tissue biopsy cultures, or cultures from other infected sites can identify the presence of M. chimaera. Mycobacterial cultures can take several weeks to grow.
- Molecular Techniques: Polymerase chain reaction (PCR) and sequencing can provide faster and more specific identification of M. chimaera.
- Imaging: Imaging studies like echocardiography, CT scans, or MRI may be necessary to assess the extent of the infection and identify any complications.
Treatment
Treating M. chimaera infection is challenging and typically requires a combination of antibiotics over an extended period, often 12 months or longer. The treatment regimen may include:
-
Antibiotic Therapy:
- Macrolides (e.g., clarithromycin or azithromycin)
- Rifampin or rifabutin
- Ethambutol
- Additional agents like aminoglycosides (e.g., amikacin), fluoroquinolones (e.g., ciprofloxacin), or linezolid may be used based on susceptibility testing and clinical response.
-
Surgical Intervention: In cases of prosthetic valve endocarditis or other localized infections, surgical removal of the infected prosthetic material or debridement of infected tissue may be necessary.
-
Monitoring and Follow-Up: Regular monitoring for side effects of prolonged antibiotic use and follow-up to assess the response to treatment is crucial. This includes clinical evaluations, blood tests, and imaging studies.
Prevention
Preventing M. chimaera infections primarily involves measures to reduce contamination of medical devices:
- Sterilization and Maintenance: Strict protocols for the sterilization and maintenance of heater-cooler units and other surgical equipment.
- Water Quality: Ensuring the water used in these devices is free from contamination with non-tuberculous mycobacteria.
- Regulatory Guidelines: Adhering to guidelines and recommendations from health authorities and manufacturers regarding the use and maintenance of heater-cooler units.
Conclusion
Mycobacterium chimaera infection is a serious health concern, particularly for patients who have undergone cardiac surgery. It presents with non-specific systemic symptoms and requires a high index of suspicion for diagnosis. Treatment involves prolonged antibiotic therapy and possibly surgical intervention. Preventive measures focusing on the sterilization and maintenance of medical devices are crucial to reducing the risk of these infections. If you suspect an M. chimaera infection, it is essential to seek medical evaluation for appropriate diagnostic testing and management.